Bruce Berkowitz is very heavy with healthcare sector. GuruFocus data show that as of September 30, a hefty 36.4 percent of his stocks money is invested in Health Care related stocks. Followed by financials (31.1%) and consumer services (21.8%):
Specifically, here are the Health Care names that Berkowitz bet his fund’s money on:
|Symbol||Price ($)||Number of Shares||Weighting(%)||Change from the 2Q09(%)||% of Company|
A brief survey of these companies:
Humana, Inc. (NYSE:HUM)
Humana, Inc. is a health services company that facilitates the delivery of health care services through networks of providers to its medical members. Humana Inc. has a market cap of $7.22 billion; its shares were traded at around $42.54 with a P/E ratio of 7.4 and P/S ratio of 0.2. Humana Inc. had an annual average earning growth of 18.7% over the past 10 years. GuruFocus rated Humana Inc. the business predictability rank of 3-star.
WellPoint, Inc. (WLP)
WellPoint, Inc. is the largest publicly traded commercial health benefits company in terms of membership in the United States. Wellpoint Inc. has a market cap of $25.94 billion; its shares were traded at around $54.61 with a P/E ratio of 8.9 and P/S ratio of 0.4. Wellpoint Inc. had an annual average earning growth of 20.8% over the past 5 years.
WellCare Health Plans, Inc. (NYSE:WCG)
WellCare Health Plans, Inc. provides managed care services targeted exclusively to government-sponsored healthcare programs, focusing on Medicaid and Medicare. WellCare provides high-quality, affordable healthcare services to members in Florida, New York, Connecticut, Illinois and Indiana. Wellcare Health Plans Inc. has a market cap of $1.5 billion; its shares were traded at around $35.31 with a P/E ratio of 28.4 and P/S ratio of 0.2.
Pfizer Inc (NYSE:PFE)
Pfizer Inc is a research-based, global pharmaceutical company. Pfizer Inc has a market cap of $126.48 billion; its shares were traded at around $18.74 with a P/E ratio of 8.5 and P/S ratio of 2.6. The dividend yield of Pfizer Inc stocks is 3.4%. Pfizer Inc had an annual average earning growth of 11% over the past 10 years.
Forest Laboratories, Inc. (NYSE:FRX)
Forest Laboratories, Inc. and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products. Forest Laboratories Inc. has a market cap of $9.52 billion; its shares were traded at around $31.56 with a P/E ratio of 9 and P/S ratio of 2.4. Forest Laboratories Inc. had an annual average earning growth of 30.7% over the past 10 years. GuruFocus rated Forest Laboratories Inc. the business predictability rank of 2-star.[
Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company is a global leader in the research and development of drugs. Bristolmyers Squibb Company has a market cap of $49.07 billion; its shares were traded at around $24.77 with a P/E ratio of 12.3 and P/S ratio of 2.3. The dividend yield of Bristolmyers Squibb Company stocks is 5%.
GuruFocus provides real time information and insights of Investment Gurus such as Warren Buffett and Bruce Berkowitz for Premium Members. If you are not a premium member, click here to sign up or upgrade. 7-Day Free Trial is available.